Karolinska Development company enrols first patient Phase Ib/IIa hepatic encephalopathy trial
27 March 2017 | By Niamh Marriott, Junior Editor
Umecrine Cognition AB announced the inclusion of the first patient in a clinical Phase Ib/IIa study of GR3027, to treat Hepatic Encephalopathy...